Tuesday, November 5, 2013

Author JK Rowling Contributes to the MS Cause


The question of how much – if anything – any of us living with multiple sclerosis is obligated to do for the cause is one of personal willingness.  When famous people get MS, many of us change our tune and simply expect that they will give of their time, money and talent for the cause.  I’ve always said that such a gift would be great but it’s none of my business.
Now we take someone who is one – albeit a small ‘one’ – degree of separation from the disease, I’d say that any expectation of requirement or obligation is just chucked out the window.
That’s why I think that the new Anne Rowling Regenerative Neurology Clinic at the University of Edinburgh, conceived and funded by Harry Potter author, JK Rowling – daughter of Anne, whodied from complications of MS at age 45 – is noteworthy.
When her £10,000,000 donation turned into a royally attended opening (in the quite Royal sense of the word as Ann, HRH The Princess Royal), Ms. Rowling didn’t give a flowery speech or make it about her in any way.  She applauded the unveiling, she was thanked by a number of dignitaries and researchers and, well there was a PRINCESS at the thing!
Her simple statement that was given to press said that she was “elated to see the clinic formally open.” And that had “watched the clinic from the planning stages to being fully built and now ready to open” and how very proud she was of it, and to see her mother’s name on the clinic.
Some in the MS community grumbled when Rowling wasn’t living up to their hopes when word first reached us that the author had a connection to MS.  As sales of the Potter books reached as high as a hippogriff can fly, more people began to assert that it was her “responsibility” to do more, say more and to be more for our cause.  I think those voices can now be silenced.
The Anne Rowling Clinic is slated to delve deeply into the cause of progression and the ways to slow this disease.  Prof Siddharthan Chandran, professor of neurology and co-director of the clinic, may have said it best in his opening remarks; “Only by better understanding the biological processes behind these devastating diseases can we identify new targets for potential therapies and take them into clinical trials.”
Knowledge is power and, as the character of Arthur Weasley, in Rowling’s books once said, “Truth will out!”
I say, ‘thank you’ once again to JK Rowling for doing more than her fair share and doing so in grand, yet humble fashion.
Wishing you and your family the best of health.
Cheers
Trevis
Don’t forget to follow me on the Life With MS Facebook page and on Twitter, and subscribe to Life With Multiple Sclerosis.

 http://www.everydayhealth.com/columns/trevis-gleason-life-with-multiple-sclerosis/author-jk-rowling-contributes-to-the-ms-cause/?xid=aol_eh-ms_5_20131104_&aolcat=AJA&icid=maing-grid7%7Chtmlws-main-bb%7Cdl30%7Csec1_lnk3%26pLid%3D401335

Monday, October 14, 2013

I Cannabis Can CURE Cancer- Just WHat does it do for MS and Other Auto Immune Disorders?

http://www.trueactivist.com/there-is-no-mistaking-the-evidence-cannabis-cures-cancer/

Do not take these antibiotics if you have MS

Ciprofloxacin (Cipro)
Levofloxacin (Levaquin)
Gemifloxacin (Factive)
Moxifloxacin (Avelox)
Norfloxacin (Noroxin)
Ofloxacin (Floxin)

“The U.S. Food and Drug Administration (FDA) has required the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs be updated to better describe the serious side effect of peripheral neuropathy.
This serious nerve damage potentially caused by fluoroquinolones may occur soon after these drugs are taken and may be permanent... The topical formulations of fluoroquinolones, applied to the ears or eyes, are not known to be associated with this risk.

See Complete article here
 http://articles.mercola.com/sites/articles/archive/2013/09/25/fluoroquinolone-antibiotics.aspx?e_cid=20130925Z1_DNL_art_1&utm_source=dnl&utm_medium=email&utm_content=art1&utm_campaign=20130925Z1

Tuesday, October 8, 2013

Tel Aviv University researchers find chemicals in marijuana could help treat MS

Share1
Multiple sclerosis is an inflammatory disease in which the immune system attacks the nervous system. The result can be a wide range of debilitating motor, physical, and mental problems. No one knows why people get the disease or how to treat it.
In a new study published in the Journal of Neuroimmune Pharmacology, Drs. Ewa Kozela, Ana Juknat, Neta Rimmerman and Zvi Vogel of Tel Aviv University's Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases and Sackler Faculty of Medicine demonstrate that some chemical compounds found in marijuana can help treat MS-like diseases in mice by preventing inflammation in the brain and spinal cord.
"Inflammation is part of the body's natural immune response, but in cases like MS it gets out of hand," says Kozela. "Our study looks at how compounds isolated from marijuana can be used to regulate inflammation to protect the nervous system and its functions." Researchers from the Weizmann Institute of Science co-authored the study.
Mind-altering findings
Israel has a strong tradition of marijuana research. Israeli scientists Raphael Mechoulam and Yechiel Gaoni discovered THC, or tetrahydrocannabinol, in 1964, kick-starting the scientific study of the plant and its chemical constituents around the world. Since then, scientists have identified about 70 compounds - called cannabinoids - that are unique to cannabis and have interesting biological effects. In the 1990s, Prof. Vogel was among the first researchers to describe endocannabinoids, molecules that act like THC in the body.
Besides THC, the most plentiful and potent cannabinoid in marijuana is cannabidiol, or CBD. The TAU researchers are particularly interested in CBD, because it offers medicinal benefits without the controversial mind-altering effects of THC.
In a 2011 study, they showed that CBD helps treat MS-like symptoms in mice by preventing immune cells in their bodies from transforming and attacking the insulating covers of nerve cells in the spinal cord. After inducing an MS-like condition in mice - partially paralyzing their limbs - the researchers injected them with CBD. The mice responded by regaining movement, first twitching their tails and then beginning to walk without a limp. The researchers noted that the mice treated with CBD had much less inflammation in the spinal cord than their untreated counterparts.

In the latest study, the researchers set out to see if the known anti-inflammatory properties of CBD and THC could also be applied to the treatment of inflammation associated with MS - and if so, how. This time they turned to the immune system.
The researchers took immune cells isolated from paralyzed mice that specifically target and harm the brain and spinal cord, and treated them with either CBD or THC. In both cases, the immune cells produced fewer inflammatory molecules, particularly one called interleukin 17, or IL-17, which is strongly associated with MS and very harmful to nerve cells and their insulating covers. The researchers concluded that the presence of CBD or THC restrains the immune cells from triggering the production of inflammatory molecules and limits the molecules' ability to reach and damage the brain and spinal cord.
Further research is needed to prove the effectiveness of cannabinoids in treating MS in humans, but there are reasons for hope, the researchers say. In many countries, CBD and THC are already prescribed for the treatment of MS symptoms, including pain and muscle stiffness.
"When used wisely, cannabis has huge potential," says Kozela, who previously studied opiates like morphine, derived from the poppy plant. "We're just beginning to understand how it works."